BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21872801)

  • 1. The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃.
    Vanoirbeek E; Krishnan A; Eelen G; Verlinden L; Bouillon R; Feldman D; Verstuyf A
    Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):593-604. PubMed ID: 21872801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and cancer: clinical aspects.
    Woloszynska-Read A; Johnson CS; Trump DL
    Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):605-15. PubMed ID: 21872802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics.
    Deeb KK; Trump DL; Johnson CS
    Nat Rev Cancer; 2007 Sep; 7(9):684-700. PubMed ID: 17721433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
    Krishnan AV; Feldman D
    Endocr Relat Cancer; 2010 Mar; 17(1):R19-38. PubMed ID: 19926709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.
    Krishnan AV; Feldman D
    Annu Rev Pharmacol Toxicol; 2011; 51():311-36. PubMed ID: 20936945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of calcitriol in cancer prevention and treatment.
    Ma J; Ma Z; Li W; Ma Q; Guo J; Hu A; Li R; Wang F; Han S
    Curr Med Chem; 2013; 20(33):4121-30. PubMed ID: 23895685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and colon cancer.
    Pereira F; Larriba MJ; Muñoz A
    Endocr Relat Cancer; 2012 Jun; 19(3):R51-71. PubMed ID: 22383428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vitamin D/CYP24A1 story in cancer.
    King AN; Beer DG; Christensen PJ; Simpson RU; Ramnath N
    Anticancer Agents Med Chem; 2010 Mar; 10(3):213-24. PubMed ID: 20184548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
    Krishnan AV; Swami S; Feldman D
    Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vitamin D in cancer prevention and treatment.
    Krishnan AV; Trump DL; Johnson CS; Feldman D
    Endocrinol Metab Clin North Am; 2010 Jun; 39(2):401-18, table of contents. PubMed ID: 20511060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D - pivotal nutraceutical in the regulation of cancer metastasis and angiogenesis.
    Xu J; Li W; Ma J; Liu J; Sha H; Zhou S; Wang F; Ma Q
    Curr Med Chem; 2013; 20(33):4109-20. PubMed ID: 23895682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer.
    Moreno J; Krishnan AV; Feldman D
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):31-6. PubMed ID: 16024246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.
    Nakagawa K; Sasaki Y; Kato S; Kubodera N; Okano T
    Carcinogenesis; 2005 Jun; 26(6):1044-54. PubMed ID: 15718253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3).
    Jones G
    Semin Dial; 2007; 20(4):316-24. PubMed ID: 17635821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-cancer actions of vitamin D.
    Chiang KC; Chen TC
    Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells.
    James SY; Mackay AG; Colston KW
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):395-401. PubMed ID: 8903423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
    Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
    Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D as a Novel Regulator of Tumor Metabolism: Insights on Potential Mechanisms and Implications for Anti-Cancer Therapy.
    Abu El Maaty MA; Wölfl S
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29048387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
    Wietzke JA; Welsh J
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.